Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
AFRIQUE

ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV


Alwihda Info | Par APO - 26 Mai 2015 modifié le 1 Janvier 1970


ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV LONDON, United-Kingdom, May 26, 2015/African Press Organization (APO)/ — ViiV Healthcare (http://www.viivhealthcare.com), Aurobindo Pharma (http://www.aurobindo.com), and the Clinton Health Access Initiative, Inc. (CHAI) (http://www.clintonhealthaccess.org) announced today that Aurobindo Pharma has […]http://feedproxy.google.com/~r/Appa-sourceTheAfric...



Dans la même rubrique :
< >

EDITORIAL | COMMUNIQUE | Informations | AFRIQUE | SCOOP | Spécial Mali | Santé | INTERVIEW | SPORTS | REACTION | MEDIAS | REPORTAGE | RELIGIONS | SERVICES | INSOLITE | ANALYSE | ARCHIVES | SCIENCE | LIVRE | Evènements